Innospec (IOSP) FY2014 results: revenue $961 million, up 17.4% on the year
Innospec Inc. (IOSP) reported revenue of $961 million for fiscal 2014, the year ended 31 December 2014, up 17.4% on the year before. Net income was $84 million, up 8.1%, and diluted earnings per share $3.38. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2015.
Revenue
$961 million
+17.4% on the year
FY2009FY2014
Operating margin
11.7%
11.1% a year earlier
FY2009FY2014
Net income
$84 million
+8.1% on the year
FY2009FY2014
Diluted EPS
$3.38
+5.0% on the year
FY2009FY2014
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Revenue
961
819
776
+17.4%
Cost of revenue
659
564
540
+16.9%
Gross profit
302
255
236
+18.3%
Gross margin
31.4%
31.2%
30.4%
Research and development
22.2
21.2
19.6
+4.7%
Selling, general and administrative
169
142
119
+19.2%
Operating income
112
90.6
96.5
+24.2%
Operating margin
11.7%
11.1%
12.4%
Interest expense
3.8
2.3
1.8
+65.2%
Pre-tax income
111
92.8
93.3
+19.5%
Income tax
26.8
15.0
26.4
+78.7%
Effective tax rate
24.2%
16.2%
28.3%
Net income
84.1
77.8
66.9
+8.1%
Net margin
8.8%
9.5%
8.6%
Diluted EPS
$3.38
$3.22
$2.81
+5.0%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Operating cash flow
106
61.3
61.3
+73.4%
Capital expenditure
13.5
11.0
8.6
+22.7%
Free cash flow
92.8
50.3
52.7
+84.5%
Free cash flow margin
9.7%
6.1%
6.8%
Cash from investing
n/a
-116
-70.3
Cash from financing
n/a
113
-44.7
Depreciation and amortisation
29.1
20.4
11.5
+42.6%
Share-based compensation
2.6
2.5
3.1
+4.0%
Buybacks
6.9
3.7
1.4
+86.5%
Dividends paid
13.4
12.0
46.7
+11.7%
Dividend per share
$0.55
$0.50
$2.00
+10.0%
Diluted shares, weighted
25m
24m
24m
+3.0%
Balance sheet
$ million
FY2014
FY2013
FY2012
On the year
Last 8 years
Shareholders' equity
516
409
317
+26.0%
Non-controlling interest
0.0
n/a
n/a
Debt
139
148
30.0
-5.8%
Other liabilities
345
237
232
+45.2%
Total liabilities and equity
1,000
795
579
+25.8%
Fixed assets
80.8
60.4
49.8
+33.8%
Goodwill
276
188
149
+46.9%
Intangible assets
181
127
68.6
+42.8%
Investments
4.7
6.6
5.1
-28.8%
Cash and equivalents
41.6
80.2
22.4
-48.1%
Receivables
164
136
116
+21.0%
Inventory
185
159
138
+16.4%
Other assets
66.4
38.1
30.5
+74.3%
Total assets
1,000
795
579
+25.8%
10-K for the year ended 31 December 2014, filed 17 February 2015: the filing.